Literature DB >> 33558997

Experimental and theoretical investigation of water-soluble silicon(IV) phthalocyanine and its interaction with bovine serum albumin.

Shaya Y Al-Raqa1, Khaoula Khezami2,3, Esra N Kaya2, Abdulkadir Kocak2, Mahmut Durmuş4.   

Abstract

Photodynamic therapy (PDT) has drawn a great scientific attention to cancer treatment over the last decades. However, the bottleneck for the PDT is to find good photosensitizers (PSs) with greater water solubility, no aggregation, and fast discharge from the body. Therefore, there are still a big scientific desire for the synthesizing new rational PSs for treatment of cancer by PDT technique. In favor of improving the competence of PDT, an axially bis[4-(diphenylamino-1,1'-biphenyl-4-ol)] substituted silicon(IV) phthalocyanine (3) was converted to its water-soluble quaternized derivative (3Q). Their structures were fully characterized by single-crystal X-ray diffraction, elemental analysis, and different spectroscopic methods such as FT-IR, UV-Vis, MALDI-TOF, and 1H-NMR. The photophysical properties such as fluorescence quantum yields and lifetimes, and the photochemical properties such as singlet oxygen generation of both phthalocyanines were investigated. Ground and excited-state calculations were performed to explain the observed electronic absorption spectra. The addition of the 4-diphenylamino-1,1'-biphenyl-4-ol groups on the axially positions of the silicon(IV) phthalocyanine increased the singlet oxygen quantum yield from 0.15 to around 0.20. Especially quaternized compound 3Q showed high singlet oxygen quantum yield of 0.26 in water solution. In addition, a spectroscopic investigation of the binding behavior of the quaternized silicon (IV) phthalocyanine complex to bovine serum albumin (BSA) is also studied in this work, confirming the possible interaction. Further theoretical calculations were carried out to find out the plausible-binding regions of the BSA protein. Axially bis[4-(diphenylamino-1,1'-biphenyl-4-ol)] substituted silicon(IV) phthalocyanine (3) was converted to its quaternized water soluble derivative (3Q). The photophysical properties such as fluorescence quantum yields and lifetimes, and the photochemical properties such as singlet oxygen generation of both phthalocyanines were investigated. In addition, a spectroscopic investigation of the binding behavior of the quaternized silicon (IV) phthalocyanine complex to bovine serum albumin (BSA) is also studied in this work, confirming the possible interaction. Further theoretical calculations were carried out to find out the plausible binding regions of the BSA protein.

Entities:  

Keywords:  BSA/DNA binding; Photodynamic therapy; Phthalocyanine; Singlet oxygen; Water soluble

Year:  2021        PMID: 33558997     DOI: 10.1007/s00775-021-01848-w

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  22 in total

Review 1.  Current clinical and preclinical photosensitizers for use in photodynamic therapy.

Authors:  Michael R Detty; Scott L Gibson; Stephen J Wagner
Journal:  J Med Chem       Date:  2004-07-29       Impact factor: 7.446

2.  Photodynamic inactivation of Candida albicans by BAM-SiPc.

Authors:  Cheung-Wai So; Paul W K Tsang; Pui-Chi Lo; C J Seneviratne; Lakshman P Samaranayake; Wing-Ping Fong
Journal:  Mycoses       Date:  2009-02-26       Impact factor: 4.377

3.  Synthesis and photodynamic activities of integrin-targeting silicon(IV) phthalocyanine-cRGD conjugates.

Authors:  Bi-Yuan Zheng; Xiao-Qing Yang; Yang Zhao; Qiao-Feng Zheng; Mei-Rong Ke; Tao Lin; Ren-Xun Chen; Kitty K K Ho; Naresh Kumar; Jian-Dong Huang
Journal:  Eur J Med Chem       Date:  2018-05-26       Impact factor: 6.514

4.  Hydroxyphthalocyanines as potential photodynamic agents for cancer therapy.

Authors:  M Hu; N Brasseur; S Z Yildiz; J E van Lier; C C Leznoff
Journal:  J Med Chem       Date:  1998-05-21       Impact factor: 7.446

Review 5.  Targeted photodynamic therapy--a promising strategy of tumor treatment.

Authors:  Andrzej M Bugaj
Journal:  Photochem Photobiol Sci       Date:  2011-05-06       Impact factor: 3.982

6.  Water-soluble cationic gallium(III) and indium(III) phthalocyanines for photodynamic therapy.

Authors:  Mahmut Durmuş; Vefa Ahsen
Journal:  J Inorg Biochem       Date:  2010-01-18       Impact factor: 4.155

Review 7.  Photodynamic therapy for cancer.

Authors:  Dennis E J G J Dolmans; Dai Fukumura; Rakesh K Jain
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

8.  The first silicon(IV) phthalocyanine-nucleoside conjugates with high photodynamic activity.

Authors:  Xiao-Min Shen; Bi-Yuan Zheng; Xiu-Rong Huang; Lei Wang; Jian-Dong Huang
Journal:  Dalton Trans       Date:  2013-08-07       Impact factor: 4.390

Review 9.  The present and future role of photodynamic therapy in cancer treatment.

Authors:  Stanley B Brown; Elizabeth A Brown; Ian Walker
Journal:  Lancet Oncol       Date:  2004-08       Impact factor: 41.316

10.  New application of phthalocyanine molecules: from photodynamic therapy to photothermal therapy by means of structural regulation rather than formation of aggregates.

Authors:  Xingshu Li; Xiao-Hui Peng; Bing-De Zheng; Jilin Tang; Yuanyuan Zhao; Bi-Yuan Zheng; Mei-Rong Ke; Jian-Dong Huang
Journal:  Chem Sci       Date:  2018-01-08       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.